Maria C. Fargnoli

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 322 publications

Predictors of outcomes and satisfaction with tirbanibulin in actinic keratosis: a multicenter real-world study.

Predictors of outcomes and satisfaction with tirbanibulin in actinic keratosis: a multicenter real-world study.

Journal: Italian journal of dermatology and venereology

Published: August 24, 2026

Clinical profile, patient experience, and management of vitiligo in Italy: Data from the National 2024 Vitiligo Week Awareness Campaign.

Clinical profile, patient experience, and management of vitiligo in Italy: Data from the National 2024 Vitiligo Week Awareness Campaign.

Journal: JAAD international

Published: August 01, 2026

The Role of General Practitioners in Actinic Keratosis Management in Europe: A Dermato-Oncologists Initiative.

The Role of General Practitioners in Actinic Keratosis Management in Europe: A Dermato-Oncologists Initiative.

Journal: Journal of clinical medicine

Published: June 30, 2026

Indicator conditions guide early HIV testing: an imperative for the Italian dermatology.

Indicator conditions guide early HIV testing: an imperative for the Italian dermatology.

Journal: Italian journal of dermatology and venereology

Published: May 26, 2026

A high-penetrance intergenic variant at 9p21 confers melanoma susceptibility.

A high-penetrance intergenic variant at 9p21 confers melanoma susceptibility.

Journal: Research square

Published: May 25, 2026

A high-penetrance intergenic variant at 9p21 confers melanoma susceptibility.

A high-penetrance intergenic variant at 9p21 confers melanoma susceptibility.

Journal: Research square

Published: May 25, 2026

Italian dermatology throughout the ages and SIDeMaST today.

Italian dermatology throughout the ages and SIDeMaST today.

Journal: Italian journal of dermatology and venereology

Published: April 16, 2026

Real-Life Effectiveness and Safety of Lebrikizumab in Elderly Patients with Atopic Dermatitis: A Multicenter Study.

Real-Life Effectiveness and Safety of Lebrikizumab in Elderly Patients with Atopic Dermatitis: A Multicenter Study.

Journal: Clinical and experimental dermatology

Published: April 12, 2026

Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study.

Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 11, 2026

A Delphi Consensus on Tildrakizumab Dosing and Titration in Moderate-to-Severe Plaque Psoriasis.

A Delphi Consensus on Tildrakizumab Dosing and Titration in Moderate-to-Severe Plaque Psoriasis.

Journal: Acta dermato-venereologica

Published: April 07, 2026

Long-Term Effectiveness of Upadacitinib in Difficult-to-Treat Psoriatic Arthritis: A 104-week Real-World Clinical and Ultrasound Study.

Long-Term Effectiveness of Upadacitinib in Difficult-to-Treat Psoriatic Arthritis: A 104-week Real-World Clinical and Ultrasound Study.

Journal: Psoriasis (Auckland, N.Z.)

Published: March 31, 2026

Health-related quality of life in individuals with Chronic hand eczema - Findings from the multinational CHECK study.

Health-related quality of life in individuals with Chronic hand eczema - Findings from the multinational CHECK study.

Journal: The Journal of dermatological treatment

Published: March 30, 2026

Showing 1-12 of 322

Last Updated: 09/26/2026